Stock Analysis

Zhongchao Full Year 2024 Earnings: US$0.12 loss per share (vs US$4.35 loss in FY 2023)

NasdaqCM:ZCMD
Source: Shutterstock
Advertisement

Zhongchao (NASDAQ:ZCMD) Full Year 2024 Results

Key Financial Results

  • Revenue: US$15.9m (down 18% from FY 2023).
  • Net loss: US$643.2k (loss narrowed by 94% from FY 2023).
  • US$0.12 loss per share (improved from US$4.35 loss in FY 2023).
earnings-and-revenue-history
NasdaqCM:ZCMD Earnings and Revenue History April 27th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Zhongchao shares are down 5.0% from a week ago.

Risk Analysis

You should learn about the 3 warning signs we've spotted with Zhongchao (including 2 which are significant).

Valuation is complex, but we're here to simplify it.

Discover if Zhongchao might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqCM:ZCMD

Zhongchao

Provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People’s Republic of China.

Flawless balance sheet slight.

Advertisement